entertainment -WSS

entertainment

author：leisure time 2025-10-01 11:47:03 - browse：7746

Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Verily hires former Apple Health leader as chief scientific officer

focus

WSS

TytoCare raises $49 million to build out AI

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

2 US Navy sailors arrested for allegedly spying for China

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

MD Anderson's Padmanee Sharma responds to research credit suit

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Wikipedia

entertainment

focus

Medical leaders decry Supreme Court decision on affirmative action

Flagship Pioneering startup Sonata Therapeutics lays off 21

At least 13 dead in Texas as scorching temps continue

The drug industry sees a key ally in the Senate prevail

The high cost of giving birth even with insurance

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Medical records are filled with copy

WATCH: Why do our ears pop?

Alkermes shareholders re

A new drug could help frostbite victims avoid its ravages

hotspot

Influencer to be charged after chaos erupts in New York City's Union Square

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

2 US Navy sailors arrested for allegedly spying for China

Ukraine seeks to reclaim its role as a hub for clinical trials

New study raises questions about niacin and heart health

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

focus

entertainment

knowledge

Wikipedia